# Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

> **NCT07109869** · PHASE3 · RECRUITING · sponsor: **pH-D Feminine Health LLC** · enrollment: 400 (estimated)

## Conditions studied

- Vulvovaginal Candidiases
- Vulvovaginal Candidiasis, Genital
- Vulvovaginal Candidiasis (VVC)

## Interventions

- **DRUG:** Boric acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07109869
- **Lead sponsor:** pH-D Feminine Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-08
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07109869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07109869, "Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07109869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*